Periodic Reporting for period 1 - LongTREC (Long-TREC: The Long-Reads Transcriptomics European Consortium. The next generation transcriptome biology revealed by single molecule sequencing technologies)
Période du rapport: 2022-10-01 au 2024-09-30
LongTREC researchers are working together to improve the methodology associated with lrRNA-seq. New bioinformatics tools are being developed to help analyze RNA sequences more efficiently, detect modifications in RNA, understand gene regulation, and even classify cancer patients more accurately; these tools are useful in studying various organisms and diseases. Advanced methods, including artificial intelligence, are helping LongTREC researchers detect changes in genes linked to diseases like cancer. Another exciting development is the use of RNA sequencing to study marine ecosystems, revealing new insights into ocean life. LongTREC members are expanding their work into multiomics looking at how different molecular processes work together. Some of these techniques are being fine-tuned to ensure they work across different species. Lastly, the team is dedicated to making these tools more user-friendly and widely available to scientists with non-bioinformatics knowledge. We are integrating our work into existing software platforms and creating easy-to-use workflows that help non-computational scientists analyze their data more effectively. Finally, LongTREC team is also developing a central resource for documentation, making it easier for others to learn and use these methods.
Two review articles have also expanded the understanding of long-read sequencing. First by Dr. Ana Conesa and LongTREC student Tianyuan Liu explores how long-read sequencing is transforming epigenomic studies, enabling direct detection of DNA methylation and RNA modifications. The second review by Dr. Eva Novoa and LongTREC student Xanthi-Lida Katopodi examines the potential of nanopore RNA sequencing in clinical applications, highlighting its ability to capture full-length transcripts and isoform diversity, offering promise for personalized medicine and diagnostics.
In summary, the LongTREC consortium’s work is advancing long-read sequencing technologies, with applications spanning from plant genomics to epigenomics and clinical diagnostics, ultimately improving the understanding of gene expression and regulatory mechanisms across various fields.
LongTREC represents a significant step forward in RNA research, bridging computational biology with real-world applications in medicine, agriculture, and environmental sciences. Through its pioneering software solutions and commitment to scientific education, LongTREC is paving the way for a deeper understanding of RNA’s role in shaping life’s complexity.